Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers.
Share:
More In Science
Rare Footage of Deep Sea Gulper Eel
Rare footage shows a deep sea gulper eel.
Chemo Shortage Hits Cancer Centers Across the U.S.
Chemo Shortage Hits Cancer Centers Across the U.S.
Moderna Expands Research & Development to China
Moderna Expands Research & Development to China
Alzheimer’s Drug Leqembi Receives Full FDA Approval
U.S. officials granted full approval to a closely watched Alzheimer’s drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for people with the brain-robbing disease.
Study Says Drinking Water From Nearly Half of US Faucets Contains Potentially Harmful Chemicals
Study Says Drinking Water From Nearly Half of US Faucets Contains Potentially Harmful Chemicals
World Sees Effects of Record High Temperatures
World Sees Effects of Record High Temperatures
World Temperature Reaches Record High For Second Consecutive Day
World Temperature Reaches Record High For Second Consecutive Day
Be Well: How to Prepare for Hurricane Season
Be Well: How to Prepare for Hurricane Season
National Weather Forecast: July 6, 2023
National weather forecast for Thursday, July 6, 2023
